Stockpiled Vaccine Can Be Recognized As Revenue In Next Fiscal Year, Says SEC
This article was originally published in The Pink Sheet Daily
Executive Summary
The "unique" nature of vaccines sold for stockpiling allows companies to record revenue without meeting traditional requirements, according to an SEC guidance.